Taken collectively, direct fluorescent labelling of antigen-adjuvant complexes may serve as critical tools in understanding subsequent immunopotentiation in vaccines directed against amyloidosis and wider dementia.
Through the use of direct fluorescent labelling, the intracytoplasmic accumulation of Aβ42 propagating as β-sheets was found in a monocytic THP-1 cell line.
The direct fluorescent labelling of a model Aβ42 amyloid antigen (4 μM) and its co-adsorbed ABA (25.0 μg/mL) utilised the fluorophores ThT and lumogallion, respectively.
In conclusion, we have demonstrated the use of direct fluorescent labelling in the cellular monitoring of amyloid when administered in simulated vaccine formulations.
The direct fluorescent labelling of a model Aβ42 peptide antigen formulated in the presence of clinically relevant and experimental ABA preparations revealed their co-localisation in the cytosol of THP-1 cells.
We adapt the TV minimization algorithm for direct fluorescent bead identification from CASSI measurements by combining a priori knowledge of the spectra associated with each bead type.
Laboratory tests include culture of the virus, direct fluorescent antibody (DFA) studies to detect virus, skin biopsy, and polymerase chain reaction to test for presence of viral DNA.
Two other tests can be carried out on a sample from the chancre: direct fluorescent antibody testing and nucleic acid amplification tests.
At necropsy, brain impressions were made and tested for rabies virus antigen by the direct fluorescent antibody test [16], [20].
Diagnosis of influenza type A infections in clinical microbiology laboratories has traditionally been performed using cell culture and/or direct fluorescent antibody assays [5] [7].
